| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 426 |
| 1 | ARIPIPRAZOLE | 84 |
| 2 | ARIPIPRAZOLE ORAL | 62 |
| 3 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 62 |
| 4 | OLANZAPINE | 61 |
| 5 | QUETIAPINE | 58 |
| 6 | LORAZEPAM | 55 |
| 7 | METFORMIN | 54 |
| 8 | METFORMIN ER 500 MG | 54 |
| 9 | METFORMIN ER 750 MG | 54 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 2 | 0.0408 |
| 1 | AMISULPRIDE | 53 | 0.0087 |
| 2 | CLOZAPINE | 426 | 0.0034 |
| 3 | HALOPERIDOL DECANOATE | 4 | 0.0023 |
| 4 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 7 | 0.0021 |
| 5 | PRAZOSIN | 11 | 0.0018 |
| 6 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 7 | 0.0017 |
| 7 | BENZTROPINE | 12 | 0.0016 |
| 8 | LITHIUM | 41 | 0.0016 |
| 9 | PYRAZINAMIDE | 14 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 478 |
| 1 | Benzodiazepine [EPC] | 114 |
| 2 | Mood Stabilizer [EPC] | 68 |
| 3 | Anti-epileptic Agent [EPC] | 65 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 55 |
| 5 | Proton Pump Inhibitor [EPC] | 52 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 39 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 22 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 9 | Osmotic Laxative [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 55 | 0.0071 |
| 1 | Atypical Antipsychotic [EPC] | 478 | 0.0011 |
| 2 | Antimycobacterial [EPC] | 16 | 0.0007 |
| 3 | Anticholinergic [EPC] | 10 | 0.0006 |
| 4 | Typical Antipsychotic [EPC] | 14 | 0.0006 |
| 5 | Cholinergic Muscarinic Agonist [EPC] | 1 | 0.0004 |
| 6 | Mood Stabilizer [EPC] | 68 | 0.0003 |
| 7 | Cholinergic Muscarinic Antagonist [EPC] | 12 | 0.0003 |
| 8 | Rifamycin Antibacterial [EPC] | 11 | 0.0003 |
| 9 | Anti-epileptic Agent [EPC] | 65 | 0.0003 |